The DOI matches its Crossref record; 575 of the 575 references it cites were found in a registry or an index.
Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
Open accessAbstract
Cardiac hypertrophy can be defined as an increase in heart mass. Pathological cardiac hypertrophy (heart growth that occurs in settings of disease, e.g. hypertension) is a key risk factor for heart failure. Pathological hypertrophy is associated with increased interstitial fibrosis, cell death and cardiac dysfunction. In contrast, physiological cardiac hypertrophy (heart growth that occurs in response to chronic exercise training, i.e. the 'athlete's heart') is reversible and is characterized by normal cardiac morphology (i.e. no fibrosis or apoptosis) and normal or enhanced cardiac function. Given that there are clear functional, structural, metabolic and molecular differences between pathological and physiological hypertrophy, a key question in cardiovascular medicine is whether mechanisms responsible for enhancing function of the athlete's heart can be exploited to benefit patients with pathological hypertrophy and heart failure. This review summarizes key experimental findings that have contributed to our understanding of pathological and physiological heart growth. In particular, we focus on signaling pathways that play a causal role in the development of pathological and physiological hypertrophy. We discuss molecular mechanisms associated with features of cardiac hypertrophy, including protein synthesis, sarcomeric organization, fibrosis, cell death and energy metabolism and provide a summary of profiling studies that have examined genes, microRNAs and proteins that are differentially expressed in models of pathological and physiological hypertrophy. How gender and sex hormones affect cardiac hypertrophy is also discussed. Finally, we explore how knowledge of molecular mechanisms underlying pathological and physiological hypertrophy may influence therapeutic strategies for the treatment of cardiovascular disease and heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–575 of 575
Localization, Anchoring, and Functions of Protein Kinase C Isozymes in the Heart
Mackay, K., & Mochly‐Rosen, D. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1400 · Cited by 139
Distinct roles of GSK-3α and GSK-3β phosphorylation in the heart under pressure overload
Matsuda, T., Zhai, P., Maejima, Y., Hong, C., Gao, S., Tian, B., Goto, K., Takagi, H., Tamamori‐Adachi, M., Kitajima, S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808315106 · Cited by 138
Robinson, E., & Grieve, D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.003 · Cited by 137
Fischer, P., & Hilfiker‐Kleiner, D. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.1 · Cited by 136
Kadokami, T., McTiernan, C. F., Kubota, T., Frye, C. S., & Feldman, A. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9307 · Cited by 136
Kong, S. W., Bodyak, N. D., Yue, P., Liu, Z., Brown, J. S., Izumo, S., & Kang, P. M. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00226.2004 · Cited by 136
Esposito, G., Prasad, S. V. N., Rapacciuolo, A., Mao, L., Koch, W. J., & Rockman, H. A. (2001) · Circulation · doi:10.1161/01.cir.103.10.1453 · Cited by 135
Cardiac hypertrophy is enhanced in PPAR -/- mice in response to chronic pressure overload
Smeets, P., Teunissen, B. E. J., Willemsen, P. H. M., van Nieuwenhoven, F. A., Brouns, A. E., Janssen, B. J., Cleutjens, J. P. M., Staels, B., Vusse, G. J., & van Bilsen, M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn001 · Cited by 135
Strøm, C. C., Aplin, M., Ploug, T., Christoffersen, T. E. H., Langfort, J., Viese, M., Galbo, H., Haunsø, S., & Sheikh, S. P. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04684.x · Cited by 134
Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis.
Ching, G. W., Franklyn, J. A., Stallard, T. J., Daykin, J., Sheppard, M. C., & GAMMAGE, M. D. (1996) · Heart · doi:10.1136/hrt.75.4.363 · Cited by 134
Li, B., Setoguchi, M., Wang, X., Andreoli, A. M., Leri, A., Malhotra, A., Kajstura, J., & Anversa, P. (1999) · Circulation Research · doi:10.1161/01.res.84.9.1007 · Cited by 134
McMullen, J., Shioi, T., Zhang, L., Tarnavski, O., Sherwood, M., Dorfman, A., Longnus, S., Pende, M., Martin, K., Blenis, J., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6231-6240.2004 · Cited by 133
Self-citationPetrich, B. G., & Wang, Y. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.11.002 · Cited by 132
The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy
Buitrago, M. A. B., Lorenz, K., Maass, A. H., Oberdorf‐Maass, S. U., Keller, U., Schmitteckert, E. M., Ivashchenko, Y., Lohse, M. J., & Engelhardt, S. H. (2005) · Nature Medicine · doi:10.1038/nm1272 · Cited by 132
Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation
Akki, A. S., Smith, K., & Seymour, A. L. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9711-y · Cited by 132
Dilated Cardiomyopathy Resulting From High-Level Myocardial Expression of Cre-Recombinase
Buerger, A., Rozhitskaya, O., Sherwood, M. C., Dorfman, A. L., Bisping, E. H., Abel, E. D., Pu, W. T., Izumo, S., & Jay, P. Y. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.03.002 · Cited by 131
Zou, Y., Hiroi, Y., Uozumi, H., Takimoto, E., Toko, H., Zhu, W., Kudoh, S., Mizukami, M., Shimoyama, M., Shibasaki, F., et al. (2001) · Circulation · doi:10.1161/01.cir.104.1.97 · Cited by 131
Regular exercise is associated with a protective metabolic phenotype in the rat heart
Burelle, Y., Wambolt, R. B., Grist, M., Parsons, H. L., Chow, J. C. F., Antler, C., Bonen, A., Keller, A., Dunaway, G., Popov, K. M., et al. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00925.2003 · Cited by 131
Kannel, W. B. (2002) · PubMed · Cited by 130
Determination of minimum sample size and discriminatory expression patterns in microarray data
Hwang, D., Schmitt, W. A., Stephanopoulos, G., & Stephanopoulos, G. N. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.9.1184 · Cited by 129
Mechanisms involved in alpha-adrenergic phenomena
Exton, J. H. (1985) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1985.248.6.e633 · Cited by 129
Sadoshima, J., Montagne, O., Wang, Q., Yang, G., Warden, J., Liu, J., Takagi, G., Karoor, V., Hong, C., Johnson, G. L., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214938 · Cited by 129
Pelzer, T., Arias-Loza, P.-A., Hu, K., Bayer, B., Dienesch, C., Calvillo, L., Couse, J. F., Korach, K. S., Neyses, L., & Ertl, G. (2005) · Circulation · doi:10.1161/01.cir.0000159262.18512.46 · Cited by 128
Protein Kinase Cα Negatively Regulates Systolic and Diastolic Function in Pathological Hypertrophy
Hahn, H. S., Marreez, Y., Odley, A. M., Sterbling, A., Yussman, M. G., Hilty, K. C., Bódi, I., Liggett, S. B., Schwartz, A., & Dorn, G. W. (2003) · Circulation Research · doi:10.1161/01.res.0000105087.79373.17 · Cited by 128
Gender-Related Differences in Myocyte Remodeling in Progression to Heart Failure
Tamura, T., Said, S., & Gerdes, A. M. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.676 · Cited by 126
The muscle Z band: lessons in stress management
Vigoreaux, J. O. (1994) · Journal of Muscle Research and Cell Motility · doi:10.1007/bf00123477 · Cited by 125
Estrogen modulation of left ventricular remodeling in the aged heart
Xu, Y. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00705-8 · Cited by 125
Clerk, A., & Sugden, P. H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00261-1 · Cited by 121
Myocyte Growth and Cardiac Repair
Anversa, P., Leri, A., Kajstura, J., & Nadal‐Ginard, B. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1506 · Cited by 120
Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy
Aronow, B. J., Toyokawa, T., Canning, A. M., Haghighi, K., Delling, U., Kranias, E. G., Molkentin, J. D., & Dorn, G. W. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.2001.6.1.19 · Cited by 120
Targeted Inhibition of Calcineurin in Pressure-overload Cardiac Hypertrophy
Hill, J. A., Rothermel, B. A., Yoo, K., Cabuay, B. M., Demetroulis, E., Weiss, R. M., Kutschke, W. J., Bassel‐Duby, R., & Williams, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110722200 · Cited by 119
Tamoxifen-inducible gene deletion in the cardiac conduction system
Hoesl, E., Stieber, J., Herrmann, S., Feil, S. C., Tybl, E., Hofmann, F. B., Feil, R., & Ludwig, A. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.04.008 · Cited by 119
GSK-3: New Thoughts on an Old Enzyme
Ferkey, D. M., & Kimelman, D. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9816 · Cited by 116
The Cardiovascular Risk of GH-Deficient Adolescents
Colao, A., Somma, C. D., Salerno, M., Spinelli, L., Orio, F., & Lombardi, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8777 · Cited by 116
Rapacciuolo, A., Esposito, G., Caron, K. M., Mao, L., THOMAS, S. A., & Rockman, H. A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01433-4 · Cited by 115
Petrich, B. G., Eloff, B. C., Lerner, D. L., Kovács, A. D., Saffitz, J. E., ROSENBAUM, D. S., & Wang, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314142200 · Cited by 114
Orenstein, T. L., Parker, T. G., BUTANY, J. W., Goodman, J. M., Dawood, F., Wang, W., Wee, L., Martino, T. A., McLaughlin, P. R., & Liu, P. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118132 · Cited by 113
Insights into the interstitium of ventricular myocardium: interstitial Cajal-like cells (ICLC)
Popescu, L. M., Gherghiceanu, M., Hinescu, M. E., Crețoiu, D., Ceafalan, L. C., Regalia, T., Popescu, A. C., Ardeleanu, C. M., & Mandache, E. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00410.x · Cited by 111
Hwang, D. M., Dempsey, A. A., Lee, C.-Y., & Liew, C. (2000) · Genomics · doi:10.1006/geno.2000.6171 · Cited by 111
Chiloeches, A., Paterson, H. F., Marais, R., Clerk, A., Marshall, C. J., & Sugden, P. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19762 · Cited by 110
Role of angiotensin II AT1 receptor activation in cardiovascular diseases
Billet, S., Aguilar, F., Baudry, C., & Clauser, É. (2008) · Kidney International · doi:10.1038/ki.2008.358 · Cited by 108
Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease
Clark, J., Sarafraz, N., & Marber, M. S. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.013 · Cited by 107
Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophy
Tsujita, Y., Muraski, J. A., Shiraishi, I., Katō, T., Kajstura, J., Anversa, P., & Sussman, M. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510138103 · Cited by 107
Multiplex Kinase Signaling Modifies Cardiac Function at the Level of Sarcomeric Proteins
Solaro, R. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800037200 · Cited by 107
Kerfant, B., Zhao, D., Lorenzen‐Schmidt, I., Wilson, L. S., Cai, S., Chen, S. R. W., Maurice, D. H., & Backx, P. H. (2007) · Circulation Research · doi:10.1161/circresaha.107.156422 · Cited by 106
Network integration of the adrenergic system in cardiac hypertrophy
Barki‐Harrington, L., Perrino, C., & Rockman, H. A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.011 · Cited by 106
Feldman, T. E., Borow, K. M., Sarne, D. H., Neumann, A., & Lang, R. M. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80213-3 · Cited by 106
Woods, R. L. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.0305-1870.2004.04073.x · Cited by 106
Kaluski, E., Cotter, G., Leitman, M., Milo‐Cotter, O., Krakover, R., Kobrin, I., Moriconi, T., Rainisio, M., Caspi, A., Reizin, L., et al. (2007) · Cardiology · doi:10.1159/000107791 · Cited by 106
Acetis, M. D., Notte, A., Accornero, F., Selvetella, G., Brancaccio, M., Vecchione, C., Sbroggió, M., Collino, F., Pacchioni, B., Lanfranchi, G., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000168028.36081.e0 · Cited by 105
Ichihara, S., Obata, K., Yamada, Y., Nagata, K., Noda, A., Ichihara, G., Yamada, A., Kato, T., Izawa, H., Murohara, T., et al. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.05.013 · Cited by 104
Cardioprotection requires taking out the trash
Gottlieb, R. A., Finley, K. D., & Mentzer, R. M. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0011-9 · Cited by 104
MicroRNAs in Cardiovascular Biology and Heart Disease
Catalucci, D., Gallo, P., & Condorelli, G. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.857425 · Cited by 104
Effects of physical training by running or swimming on ventricular performance of rat hearts
Schaible, T. F., & Scheuer, J. (1979) · Journal of Applied Physiology · doi:10.1152/jappl.1979.46.4.854 · Cited by 104
MicroRNA: a new frontier in kidney and blood pressure research
Liang, M., Liu, Y., Mladinov, D., Cowley, A. W., Trivedi, H., Fang, Y., Xu, X., Ding, X., & Tian, Z. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00045.2009 · Cited by 104
García-Sáinz, J. A., Vázquez‐Prado, J., & Villalobos‐Molina, R. (1999) · Archives of Medical Research · doi:10.1016/s0188-0128(99)00059-7 · Cited by 104
Cardiac 1-adrenergic drive in pathological remodelling
Woodcock, E. A., Du, X.-J., Reichelt, M. E., & Graham, R. M. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm078 · Cited by 103
Pu, W. T., Ma, Q., & Izumo, S. (2003) · Circulation Research · doi:10.1161/01.res.0000069211.82346.46 · Cited by 102
Fan, G., Yuan, Q., Song, G., Wang, Y., Chen, G., Qian, J., Zhou, X., Lee, Y. J., Ashraf, M., & Kranias, E. G. (2006) · Circulation Research · doi:10.1161/01.res.0000251074.19348.af · Cited by 102
Postnatal Growth of the Heart and Its Blood Vessels
HUDLICKÁ, O., & Brown, M. D. (2008) · Journal of Vascular Research · doi:10.1159/000159155 · Cited by 101
Nuñez, S. B., Medin, J. A., Braissant, O., Kemp, L., Wahli, W., Ozato, K., & Segars, J. H. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(96)03980-9 · Cited by 101
MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq
Minamino, T., Yujiri, T., Terada, N., Taffet, G. E., Michael, L. H., Johnson, G. L., & Schneider, M. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062453699 · Cited by 100
Cardiac mechanotransduction and implications for heart disease
Knöll, R., Hoshijima, M., & Chien, K. R. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0488-x · Cited by 100
Deitch, R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92954-4 · Cited by 100
Myocardial Phosphodiesterases and Regulation of Cardiac Contractility in Health and Cardiac Disease
Osadchii, O. E. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6014-6 · Cited by 99
Steroid Hormone Interactions with Target Cells: Cross Talk between Membrane and Nuclear Pathways
Farach‐Carson, M. C., & Davis, P. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055038 · Cited by 98
Increased Myocardial Rab GTPase Expression: A Consequence and Cause of Cardiomyopathy
Wu, G., Yussman, M. G., Barrett, T. J., Hahn, H. S., Osińska, H. E., Hilliard, G. M., Wang, X., Toyokawa, T., Yatani, A., Lynch, R. A., et al. (2001) · Circulation Research · doi:10.1161/hh2401.100427 · Cited by 95
Kovačič-Milivojević, B., Roediger, F. C., Almeida, E. A. C., Damsky, C. H., Gardner, D. G., & Ilić, D. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2290 · Cited by 95
Hsp20 and Its Cardioprotection
Fan, G., CHU, G., & Kranias, E. G. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.05.004 · Cited by 94
Role of the renin-angiotensin system in cardiac hypertrophy
Yamazaki, T., Komuro, I., & Yazaki, Y. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00259-3 · Cited by 93
Sakamoto, M., Minamino, T., Toko, H., Kayama, Y., Zou, Y., Sano, M., Takaki, E., Aoyagi, T., Tojo, K., Tajima, N., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000252345.80198.97 · Cited by 92
Laskowski, A., Woodman, O. L., CAO, A., Drummond, G. R., Marshall, T. P., Kaye, D. M., & Ritchie, R. H. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.07.006 · Cited by 91
Lu, Z.-J., Jiang, Y.-P., Wang, W., Xu, X.-H., Mathias, R., Entcheva, E., Ballou, L., Cohen, I. S., & Lin, R. (2009) · Circulation · doi:10.1161/circulationaha.109.873380 · Cited by 91
Monitoring tissue repair and fibrosis from a distance.
Kt, W. (1997) · PubMed · Cited by 91
Antiadrenergic Therapy of Chronic Heart Failure
Bristow, M. R. (2003) · Circulation · doi:10.1161/01.cir.0000054530.87613.36 · Cited by 89
gp130 Plays a Critical Role in Pressure Overload-induced Cardiac Hypertrophy
Uozumi, H., Hiroi, Y., Zou, Y., Takimoto, E., Toko, H., Niu, P., Shimoyama, M., Yazaki, Y., Nagai, R., & Komuro, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100814200 · Cited by 86
MicroRNA and cardiac pathologies
Latronico, M. V. G., Catalucci, D., & Condorelli, G. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90254.2008 · Cited by 86
Du, X., Lu, F. Y., & Kiriazis, H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.016 · Cited by 84
Petrich, B. G., Molkentin, J. D., & Wang, Y. (2003) · The FASEB Journal · doi:10.1096/fj.02-0438fje · Cited by 84
Mechanisms of Estrogen Receptor Action in the Myocardium
de Jager, T., Pelzer, T., Müller-Botz, S., Imam, A., Muck, J., & Neyses, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010984200 · Cited by 84
Heart Hypertrophy During Pregnancy: A Better Functioning Heart?
Eghbali, M., Wang, Y., Toro, L., & Stefani, E. (2006) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.07.001 · Cited by 83
Targeting p38-MAPK in the ischaemic heart: kill or cure?
BASSI, R., Heads, R. J., Marber, M. S., & Clark, J. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.01.002 · Cited by 83
Billet, S., Bardin, S., Verp, S., Baudrie, V., Michaud, A., Conchon, S., Muffat‐Joly, M., Escoubet, B., Souil, E., Hamard, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28764 · Cited by 83
Prevalence of cardiac structural and functional abnormalities in untreated primary hypertension.
Laufer, E., Jennings, G., Korner, P. I., & Dewar, E. (1989) · Hypertension · doi:10.1161/01.hyp.13.2.151 · Cited by 82
Construction of a Human Cardiovascular cDNA Microarray: Portrait of the Failing Heart
Barrans, J. D., Stamatiou, D., & Liew, C. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4137 · Cited by 82
Iemitsu, M., Miyauchi, T., Maeda, S., Sakai, S., FUJII, N. L., Miyazaki, H., Kakinuma, Y., Matsuda, M., & Yamaguchi, I. (2003) · Hypertension Research · doi:10.1291/hypres.26.829 · Cited by 82
Harada, K., Komuro, I., Zou, Y., Kudoh, S., Kijima, K., Matsubara, H., Sugaya, T., Murakami, K., & Yazaki, Y. (1998) · Circulation Research · doi:10.1161/01.res.82.7.779 · Cited by 82
Sex Hormones and Cardiomyopathic Phenotype Induced by Cardiac β2-Adrenergic Receptor Overexpression
Gao, X., Agrotis, A., Autelitano, D. J., Percy, E., Woodcock, E. A., Jennings, G., Dart, A. M., & Du, X. (2003) · Endocrinology · doi:10.1210/en.2002-0214 · Cited by 81
Liu, W., Zi, M., Jin, J., Prehar, S., Oceandy, D., Kimura, T. E., Lei, M., Neyses, L., Weston, A. H., Cartwright, E. J., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.188292 · Cited by 81
Kedzierski, R. M., Grayburn, P. A., Kisanuki, Y. Y., Williams, C. S., Hammer, R. E., Richardson, J. A., Schneider, M. D., & Yanagisawa, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8226-8232.2003 · Cited by 81
Thyroid Hormone-Regulated Cardiac Gene Expression and Cardiovascular Disease
Danzi, S. E., & Klein, I. L. (2002) · Thyroid · doi:10.1089/105072502760143836 · Cited by 81
Lipids in the heart: a source of fuel and a source of toxins
Park, T., Yamashita, H., Blaner, W. S., & Goldberg, I. J. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32814a57db · Cited by 80
Okere, I. C., Chess, D. J., McElfresh, T. A., Johnson, J., Rennison, J., Ernsberger, P., Hoit, B. D., Chandler, M. P., & Stanley, W. C. (2005) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2005.04272.x · Cited by 79
Carpenter, G. F., & Cohen, S. (1984) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(84)90129-4 · Cited by 79
Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency
Horiuchi, M., Yoshida, H., Kobayashi, K., Kuriwaki, K., Yoshimine, K., Tomomura, M., Koizumi, T., Nikaido, H., Hayakawa, J.-I., Kuwajima, M., et al. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81805-a · Cited by 78
Zhu, Y., Zhu, Y. Z., Gohlke, P., Stauss, H. M., & Unger, T. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00465-7 · Cited by 78
Zhai, P., Gao, S., Holle, E., Yu, X., Yatani, A., Wagner, T. E., & Sadoshima, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705133200 · Cited by 76
Persistent IGF‐I overexpression in skeletal muscle transiently enhances DNA accretion and growth 1
Fiorotto, M. L., Schwartz, R. J., & Delaughter, M. C. (2003) · The FASEB Journal · doi:10.1096/fj.02-0289fje · Cited by 76
Sullivan, J. L. (2003) · American Heart Journal · doi:10.1067/mhj.2003.142 · Cited by 75
The low-affinity site of the β1-adrenoceptor and its relevance to cardiovascular pharmacology
Kaumann, A. J., & Molenaar, P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.03.009 · Cited by 75
Clerk, A., Aggeli, I.-K. S., Σταθοπούλου, Κ., & Sugden, P. H. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.04.005 · Cited by 74
Diffee, G. M., Seversen, E. A., Stein, T. D., & Johnson, J. A. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00761.2002 · Cited by 74
Hypertrophic growth of cultured neonatal rat heart cells mediated by type 1 angiotensin II receptor
宮田, 節., & Haneda, T. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.6.h2443 · Cited by 74
Inducible and cardiac specific PTEN inactivation protects ischemia/reperfusion injury
Ruan, H., Li, J., Ren, S. V., Gao, J., Li, G., Kim, R., Wu, H., & Wang, Y. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.021 · Cited by 73
Kasahara, H., Ueyama, T., Wakimoto, H., Liu, M. K., Maguire, C. T., Converso, K. L., Kang, P. M., Manning, W. J., Lawitts, J., Paul, D. L., et al. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00002-6 · Cited by 73
Pressure-overload hypertrophy is unabated in mice devoid of AT1Areceptors
Hamawaki, M., Coffman, T. M., Lashus, A. G., Koide, M., Zile, M. R., Oliverio, M. I., DeFreyte, G., Cooper, G., & Carabello, B. A. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.3.h868 · Cited by 73
Cardiac function in hypertrophied hearts from chronically exercised female rats
Schaible, T. F., & Scheuer, J. (1981) · Journal of Applied Physiology · doi:10.1152/jappl.1981.50.6.1140 · Cited by 73
Ma, H., Sprecher, H. W., & Kolattukudy, P. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30131 · Cited by 72
Sex differences in cardiac adaptation to essential hypertension
Garavaglia, G., Messerli, F. H., Schmieder, R. E., Núñez, B. D., & Oren, S. (1989) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059434 · Cited by 70
Boluyt, M. O., Brevick, J. L., Rogers, D. S., Randall, M. J., Scalia, A. F., & Li, Z. B. (2006) · PROTEOMICS · doi:10.1002/pmic.200401356 · Cited by 69
Up-Regulation of Angiotensin II Type 2 Receptor in Rat Thoracic Aorta by Pressure-Overload
Yayama, K., Horii, M., Hiyoshi, H., Takano, M., Okamoto, H., Kagota, S., & Kunitomo, M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058420 · Cited by 68
Maass, A. H., Ikeda, K., Oberdorf‐Maass, S. U., Maier, S. K. G., & Leinwand, L. A. (2004) · Circulation · doi:10.1161/01.cir.0000144460.84795.e3 · Cited by 68
Modesti, P. A., Vanni, S., Bertolozzi, I., Cecioni, I., Polidori, G., Paniccia, R., Bandinelli, B., Perna, A. M., Liguori, P., Boddi, M., et al. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h976 · Cited by 67
JNK1 is required to preserve cardiac function in the early response to pressure overload
Tachibana, H., Perrino, C., Takaoka, H., Davis, R. J., Prasad, S. V. N., & Rockman, H. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.065 · Cited by 66
Stimulus specific changes of energy metabolism in hypertrophied heart
Rimbaud, S., Sanchez, H., Garnier, A., Fortin, D., Bigard, X. A., Veksler, V., & Ventura‐Clapier, R. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.01.013 · Cited by 66
Assembly of Myofibrils in Cardiac Muscle Cells
Sanger, J. W., Ayoob, J. C., Chowrashi, P. K., et al. (2000) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4267-4_6 · Cited by 65
Dash, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00772-1 · Cited by 65
Alterations in apoptosis regulatory factors during hypertrophy and heart failure
Kang, P. M., Yue, P., Liu, Z., Tarnavski, O., Bodyak, N. D., & Izumo, S. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00556.2003 · Cited by 64
PKC-β is not necessary for cardiac hypertrophy
Roman, B. B., Geenen, D. L., Leitges, M., et al. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.5.h2264 · Cited by 62
Salerno, M., Esposito, V., Spinelli, L., Somma, C. D., Farina, V., Muzzica, S., de Horatio, L. T., Lombardi, G., & Colao, A. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02026.x · Cited by 59
Adaptation of the rat cardiac proteome in response to intensity‐controlled endurance exercise
Burniston, J. G. (2008) · PROTEOMICS · doi:10.1002/pmic.200800268 · Cited by 58
Estrogen Replacement and Cardiomyocyte Protection
Patten, R. D., & Karas, R. H. (2006) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.01.002 · Cited by 58
Effect of growth hormone administration and treadmill exercise on serum and skeletal IGF-I in rats
Yeh, J. K., Aloia, J. F., Chen, M., et al. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.1.e129 · Cited by 58
Perrino, C., Schroder, J. N., Lima, B., Villamizar, N. R., Nienaber, J. J., Milano, C. A., & Prasad, S. V. N. (2007) · Circulation · doi:10.1161/circulationaha.107.706515 · Cited by 57
Effects of Fenofibrate on Cardiac Remodeling in Aldosterone-Induced Hypertension
LeBrasseur, N. K., Duhaney, T.-A. S., Silva, D. S. D., Cui, L., Ip, P. C., Joseph, L., & Sam, F. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.092403 · Cited by 56
Clinical trials of endothelin antagonists in heart failure: a question of dose?
Kelland, N. F., & Webb, D. J. (2006) · PubMed · Cited by 56
Catecholamines in cardiac hypertrophy
Scheuer, J. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00264-7 · Cited by 55
Estigoy, C., Pontén, F., Odeberg, J., Herbert, B. R., Guilhaus, M., Charleston, M., Ho, J. W. K., Cameron, D., & dos Remedios, C. G. (2009) · Biophysical Reviews · doi:10.1007/s12551-008-0007-y · Cited by 55
Effects of thyroid status on expression of voltage-gated potassium channels in rat left ventricle
Nishiyama, A., Kambe, F., Kamiya, K., Seo, H., & Toyama, J. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00135-7 · Cited by 55
Kiriazis, H., Wang, K. K., Xu, Q., Gao, X., Ming, Z., Su, Y. R., Moore, X., Lambert, G. W., Gibbs, M. E., Dart, A. M., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707622 · Cited by 54
Fundamental considerations of β-adrenoceptor subtypes in human heart failure
Molenaar, P., & Parsonage, W. A. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.05.005 · Cited by 54
Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors
Gembardt, F., Heringer‐Walther, S., van Esch, J. H. M., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-108316 · Cited by 52
A Transgenic Mouse Model of Heart Failure Using Inducible Gαq
Fan, G., Jiang, Y., Lu, Z., Martin, D. W., Kelly, D. J., Zuckerman, J. M., Ballou, L. M., Cohen, I. S., & Lin, R. Z. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506810200 · Cited by 52
Activation of JNK in the Remote Myocardium after Large Myocardial Infarction in Rats
Li, W. G., Zaheer, A., Coppey, L. J., & Oskarsson, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8662 · Cited by 52
Scheinowitz, M., Kessler‐Icekson, G., Freimann, S., Zimmermann, R., Schaper, W. K. A., Golomb, E., Savion, N., & Eldar, M. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00137-5 · Cited by 50
Shulman, D. I., Root, A. W., Diamond, F., Bercu, B. B., Martinez, R., & Boucek, R. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030030 · Cited by 49
Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and disease
Lorell, B. H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00258-1 · Cited by 48
Bourdoncle, A., Labesse, G., Margueron, R., Castet‐Nicolas, A., Cavaillès, V., & Royer, C. A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.01.048 · Cited by 47
Torres, F. (2013) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-12.3.118 · Cited by 47
TISSUE RENIN-ANGIOTENSIN SYSTEM:A Site of Drug Action?
and, B. G. Z., & Dunham, E. W. (1997) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.53 · Cited by 46
Influence of Age and Sex on Left Ventricular Anatomy and Function in Normals
Grandi, A. M., Venco, A., Barzizza, F., Scalise, F., Pantaleo, P., & Finardi, G. (2008) · Cardiology · doi:10.1159/000175770 · Cited by 45
Therapeutic options in minimizing left ventricular hypertrophy
Devereux, R. B. (2000) · American Heart Journal · doi:10.1067/mhj.2000.102902 · Cited by 44
Linz, W., Wohlfart, P., Baader, M., Breitschopf, K., Falk, E., Schäfer, H., Gerl, M., Kramer, W., & Rütten, H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.58 · Cited by 44
Targeting histone deacetylases for heart failure
Bush, E. W., & McKinsey, T. A. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902939161 · Cited by 43
Takahashi, R., Asai, T., Murakami, H., Murakami, R., Tsuzuki, M., Numaguchi, Y., Matsui, H., Murohara, T., & Okumura, K. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.088609 · Cited by 43
Henderson, B. C., Sen, U., Reynolds, C. L., Moshal, K. S., Ovechkin, A. V., Tyagi, N., Kartha, G., Rodriguez, W. E., & Tyagi, S. C. (2007) · International Journal of Biological Sciences · doi:10.7150/ijbs.3.385 · Cited by 42
Sopontammarak, S., Aliharoob, A., Ocampo, C., Arcilla, R. A., Gupta, M. P., & Gupta, M. (2005) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:43:1:061 · Cited by 41
Chronic swimming reverses cardiac dysfunction and myosin abnormalities in hypertensive rats
Schaible, T. F., Malhotra, A., Ciambrone, G., et al. (1986) · Journal of Applied Physiology · doi:10.1152/jappl.1986.60.4.1435 · Cited by 41
Chronic heart failure: an overview of conventional treatment versus novel approaches
Landmesser, U., & Drexler, H. (2005) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0371 · Cited by 40
To Cre or Not To Cre: The Next Generation of Mouse Models of Human Cardiac Diseases
Chien, K. R. (2001) · Circulation Research · doi:10.1161/01.res.88.6.546 · Cited by 39
Deficit of CD38/cyclic ADP-ribose is differentially compensated in hearts by gender
Takahashi, J., Kagaya, Y., Kato, I., Ohta, J., Isoyama, S., Miura, M., Sugai, Y., Hirose, M., Wakayama, Y., Ninomiya, M., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.143 · Cited by 37
IMPACT OF MULTIPLE GENE MUTATIONS IN DETERMINING THE SEVERITY OF CARDIOMYOPATHY AND HEART FAILURE
Tsoutsman, T., Bagnall, R. D., & Semsarian, C. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05037.x · Cited by 37
Kuwajima, M., Lu, K., Sei, M., Ono, A., Hayashi, M., Ishiguro, K., Ozaki, K., Hotta, K., Okita, K., Murakami, T., et al. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0641 · Cited by 36
Exercise training in heart failure
Coats, A. J. S. (2000) · Trials · doi:10.1186/cvm-1-3-155 · Cited by 36
Miyazaki, H., Oka, N., Koga, A., Ohmura, H., Ueda, T., & Imaizumi, T. (2006) · Hypertension Research · doi:10.1291/hypres.29.1029 · Cited by 33
Weiss, R. E., Korcarz, C. E., Chassande, O., Cua, K., Sadow, P. M., Koo, E., Samarut, J., & Lang, R. M. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00019.2002 · Cited by 33
ROLE OF INSULIN‐LIKE GROWTH FACTOR 1 AND PHOSPHOINOSITIDE 3‐KINASE IN A SETTING OF HEART DISEASE
McMullen, J. R. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04873.x · Cited by 32
Self-citationNew insights into the regulation of angiotensin receptors
Mogi, M., Iwai, M., & Horiuchi, M. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328324f5fa · Cited by 29
Tackling the EGFR in pathological tissue remodelling
Chan, H., Smith, N. J., Hannan, R. D., & Thomas, W. G. (2005) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2005.04.005 · Cited by 28
MECHANISMS FOR REDUCTION OF CARDIOVASCULAR RISK BY REGULAR EXERCISE
Jennings, G. (1995) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1995.tb01982.x · Cited by 28
New Insights Into the Role of Apoptosis in Cardiovascular Disease
Kang, P. M., Yue, P., & Izumo, S. (2002) · Circulation Journal · doi:10.1253/circj.66.1 · Cited by 22
Liu, J., Chan, P., Chen, J.-J., Lee, H.-M., Lee, W., Shih, N., Chen, Y., Hong, H.-J., & Cheng, T. (2004) · Journal of Biomedical Science · doi:10.1007/bf02256544 · Cited by 21
Role of PI3 Kinase Gamma in Excitation-Contraction Coupling and Heart Disease
Oudit, G. Y., & Kassiri, Z. (2007) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152907782793545 · Cited by 21
Unveiling gender differences in demand ischemia: a study in a rat model of genetic hypertension
Podesser, B. K., Jain, M., Ngoy, S., Apstein, C. S., & Eberli, F. R. (2006) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2006.10.041 · Cited by 21
Cardiac Adaptation to Ischemia‐Reperfusion Injurya
Kingma, J. G. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09227.x · Cited by 18
Measurement of myocardial free radical production during exercise using EPR spectroscopy
Traverse, J. H., Nesmelov, Y. E., Crampton, M. J., Lindstrom, P., Thomas, D. D., & Bache, R. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00412.2005 · Cited by 18
Pressure overload induces greater hypertrophy and mortality in female mice with p38α MAPK inhibition
Liu, J., Sadoshima, J., Zhai, P., Hong, C., Yang, G., Chen, W., Yan, L., Wang, Y., Vatner, S. F., & Vatner, D. E. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.07.007 · Cited by 16
The protective effects of exercise and phosphoinositide 3-kinase (p110α) in the failing heart
Owen, K., Pretorius, L., & McMullen, J. R. (2009) · Clinical Science · doi:10.1042/cs20080183 · Cited by 15
Self-citationDisparate Regulation of Signaling Proteins after Exercise and Myocardial Infarction
Gosselin, H., Béliveau, L., Burelle, Y., et al. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000205138.02440.79 · Cited by 13
DISTINCT ROLE OF ADRENOCEPTOR SUBTYPES IN CARDIAC ADAPTATION TO CHRONIC PRESSURE OVERLOAD
Du, X. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04871.x · Cited by 12
Schiffrin, E. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-386525-0.00028-7 · Cited by 12
Jalil, M. A., Horiuchi, M., Wakamatsu, M., et al. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj032 · Cited by 8
Myocardial Basis for Heart Failure
Owen, A. A., & Spinale, F. G. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10005-1 · Cited by 8
Genetic basis of hypertrophic cardiomyopathy
Lind, J., Chiu, C. L., & Semsarian, C. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.6.927 · Cited by 5
Signal Transduction of Cardiac Myocyte Hypertrophy
Aoki, H., & Izumo, S. (2001) · Elsevier eBooks · doi:10.1016/b978-012656975-9/50060-2 · Cited by 4
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Physiological and pathological cardiac hypertrophy
Shimizu, I., & Minamino, T. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.06.001 · Cited by 887
Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis
Fang, X., Cai, Z., Wang, H., Han, D., Cheng, Q., Zhang, P., Gao, F., Yu, Y., Song, Z., Wu, Q., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316509 · Cited by 770
Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1477-x · Cited by 708
Self-citationHuynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Self-citation
Metadata
- Authors
- Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 128
- Issue
- 1
- Pages
- 191-227
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2021458745
- Cited by
- 894
- References
- 575
- FWCI
- 25.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.